Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 3:31 pm Purchase | 2025-03-31 | 13G | Momentus Inc. MNTS | Armistice Capital, LLC | 500,958 9.990% | 321,500 (+179.15%) | Filing History |
| 2025-05-15 3:31 pm Purchase | 2025-03-31 | 13G | MacroGenics, Inc. MGNX | Armistice Capital, LLC | 6,296,000 9.980% | 20,000 (+0.32%) | Filing History |
| 2025-05-15 3:30 pm Purchase | 2025-03-31 | 13G | Moleculin Biotech, Inc. MBRX | Armistice Capital, LLC | 1,250,000 8.930% | 910,233 (+267.90%) | Filing History |
| 2025-05-15 3:30 pm Purchase | 2025-03-31 | 13G | LM Funding America, Inc. LMFA | Armistice Capital, LLC | 535,339 9.990% | 131,188 (+32.46%) | Filing History |
| 2025-05-15 3:29 pm Purchase | 2025-03-31 | 13G | Presidio Property Trust, Inc. SQFT | Armistice Capital, LLC | 157,092 9.990% | 81,440 (+107.65%) | Filing History |
| 2025-05-15 3:29 pm Purchase | 2025-03-31 | 13G | Kura Oncology, Inc. KURA | Armistice Capital, LLC | 6,572,000 7.590% | 772,000 (+13.31%) | Filing History |
| 2025-05-15 3:29 pm Purchase | 2025-03-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | Armistice Capital, LLC | 13,700,000 8.470% | 4,232,000 (+44.70%) | Filing History |
| 2025-05-15 3:29 pm Purchase | 2025-03-31 | 13G | SuperCom Ltd. SPCB | Armistice Capital, LLC | 441,692 9.990% | 441,692 (New Position) | Filing History |
| 2025-05-15 3:28 pm Sale | 2025-03-31 | 13G | Intensity Therapeutics, Inc. INTS | Armistice Capital, LLC | 872,547 5.750% | -254,321 (-22.57%) | Filing History |
| 2025-05-15 3:28 pm Unchanged | 2025-03-31 | 13G | Globus Maritime Limited GLBS | Armistice Capital, LLC | 1,200,000 5.510% | 0 (Unchanged) | Filing History |
| 2025-05-15 3:28 pm Purchase | 2025-03-31 | 13G | Stardust Power Inc. SDST | Armistice Capital, LLC | 452,600 8.200% | 452,600 (New Position) | Filing History |
| 2025-05-15 3:27 pm Purchase | 2025-03-31 | 13G | PDS Biotechnology Corporation PDSB | Armistice Capital, LLC | 4,547,925 9.990% | 4,547,925 (New Position) | Filing History |
| 2025-05-15 3:27 pm Purchase | 2025-03-31 | 13G | FibroGen, Inc. FGEN | Armistice Capital, LLC | 340,000 8.420% | 68,000 (+25.00%) | Filing History |
| 2025-05-15 3:27 pm Sale | 2025-03-31 | 13G | Enlivex Therapeutics Ltd. ENLV | Armistice Capital, LLC | 1,781,931 7.530% | -426,069 (-19.30%) | Filing History |
| 2025-05-15 3:27 pm Purchase | 2025-03-31 | 13G | Processa Pharmaceuticals, Inc. PCSA | Armistice Capital, LLC | 578,605 9.990% | 578,605 (New Position) | Filing History |
| 2025-05-15 3:27 pm Purchase | 2025-03-31 | 13G | Ekso Bionics Holdings, Inc. EKSO | Armistice Capital, LLC | 13,319 9.990% | 3,319 (+33.19%) | Filing History |
| 2025-05-15 3:26 pm Purchase | 2025-03-31 | 13G | Dermata Therapeutics, Inc. DRMA | Armistice Capital, LLC | 106,508 9.990% | 78,865 (+285.31%) | Filing History |
| 2025-05-15 3:25 pm Sale | 2025-03-31 | 13G | DANIMER SCIENTIFIC INC DNMRQ | Armistice Capital, LLC | 89,999 9.990% | -81,762 (-47.60%) | Filing History |
| 2025-05-15 3:25 pm Sale | 2025-03-31 | 13G | ALTAMIRA THERAPEUTICS LTD SHS CYTOF | Armistice Capital, LLC | 473,870 9.990% | -4,677 (-0.98%) | Filing History |
| 2025-05-15 3:24 pm Purchase | 2025-03-31 | 13G | Oxbridge Re Holdings Limited OXBR | Armistice Capital, LLC | 622,165 8.360% | 622,165 (New Position) | Filing History |